A U.S. biotechnology firm, Colossal Biosciences, has successfully hatched 26 healthy baby chickens using an artificial egg platform at its headquarters in Dallas, Texas, the company told Reuters in a report published on May 22, 2026. Colossal, which specializes in de-extinction research, designed a bioengineered silicone-based membrane housed in a rigid shell to replicate key functions of a natural eggshell, including gas exchange, moisture control, thermal stability and structural support. The chicken embryos, transferred with their yolks into the device, developed over about 21 days, matching normal chicken incubation times. The company is now monitoring the chicks’ growth and health outcomes.
Prepared by Olivia Bennett and reviewed by editorial team.
This breakthrough could revolutionize poultry farming, potentially reducing costs and improving conditions for chickens. If you're concerned about animal welfare or the price of your eggs, keep an eye on this tech.
Colossal Biosciences' artificial egg platform is a game-changer in biotechnology. It's still early days, but if the chicks continue to thrive, we could see a new era in sustainable farming. Worth forwarding if you know someone who loves a good science breakthrough.
Not specified in source.
Not specified in source.
No left-leaning sources found for this story.
No right-leaning sources found for this story.
Comments